Troponin autoantibodies: From assay interferent to mediator of cardiotoxicity

Clinical Chemistry

Volumn 63, Issue 1, 2017, Pages 30-32

  Park, Jason Y ^a   Jaffe, Allan S ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROGRAMMED DEATH 1 RECEPTOR; RHEUMATOID FACTOR; TROPONIN; TROPONIN I; AUTOANTIBODY; EPITOPE; TROPONIN T;

AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; EDITORIAL; HEART INFARCTION; HUMAN; IMMUNOASSAY; MYOCARDITIS; PATHOGENESIS;

AUTOANTIBODIES; CARDIOTOXICITY; EPITOPES; HUMANS; TROPONIN I; TROPONIN T;

EID: 85008490032     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2016.268920     Document Type: Editorial

References (15)

1. Bohner J, Von Pape KW, Hannes W, Stegmann T. False-negative immunoassay results for cardiac troponin Iprobably due to circulating troponin Iautoantibodies. Clin Chem 1996;42:2046.
2. Heinzerling L, Ott PA, Hodi FS, Husain AN, Tajmir-Riahi A, Tawbi H, et al. Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy. J Immunother Cancer 2016;4:50.
3. Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, et al. Autoantibodies againstcardiactroponinIareresponsible fordilatedcardiomyopathyinPD-1-deficient mice. Nat Med 2003;9:1477-83.
4. Vylegzhanina AV, Kogan AE, Katrukha IA, Antipova OV, Kara AN, Bereznikova AV, et al. Anti-cardiac troponin autoantibodies are specific to the conformational epitopes formed by cardiac TnI and TnT in the ternary troponin complex. Clin Chem 2017;63:343-50.
5. Adamczyk M, Brashear RJ, Mattingly PG. Circulating cardiac troponin-I autoantibodies in human plasma and serum. Ann NY Acad Sci 2009;1173:67-74.
6. Savukoski T, Ilva T, Lund J, Ristiniemi N, Wittfooth S, Pettersson K. Autoantibody prevalence with an improved immunoassay for detecting cardiac troponin-specific autoantibodies. Clin Chem Lab Med 2014;52:273-9.
7. Savukoski T, Engstrom E, Engblom J, Ristiniemi N, Wittfooth S, Lindahl B, et al. Troponin-specific autoantibody interference in different cardiac troponin I assay configurations. Clin Chem 2012;58:1040-8.
8. Pettersson K, Eriksson S, Wittfooth S, Engström E, Nieminen M, Sinisalo J. Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients. Clin Chem 2009;55:938-45.
9. O'Donohoe TJ, Ketheesan N, Schrale RG. Anti-troponin antibodies following myocardial infarction. J Cardiol 2016; pii: S0914-5087:30172-1.
10. Goser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Ottl R, et al. Cardiac troponinIbut not cardiac troponinTinduces severe autoimmune inflammationinthe myocardium. Circulation 2006;114:1693-702.
11. Halley CM, Lappe JM, Cotleur AC, Shrestha K, Borowski AG, Pelfrey C, et al. Antiinflammatory autoimmune cellular responsestocardiac troponinI inidiopathic dilated cardiomyopathy. J Card Fail 2011;17:359-65.
12. Gottumukkala RV, Lv H, Cornivelli L, Wagers AJ, Kwong RY, Bronson R, et al. Myocardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes. Sci Transl Med 2012;4:138ra80.
13. Leuschner F, Li J, Goser S, Reinhardt L, Ottl R, Bride P, et al. Absenceofauto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Eur Heart J 2008;29:1949-55.
14. Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001;291:319-22.
15. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH, et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995;3:541-7.